INTRODUCTION
Maternal floor infarction of the placenta (MFI) is a pathologic entity described by Benirschke and Driscoll in 1961 characterized by deposition of fibrinoid material in the maternal surface and intervillous spaces of the placenta 1 ( Figure 1 ). The etiology remains uncertain; however, it has clearly been associated with significant perinatal morbidity and mortality including stillbirths, recurrent pregnancy loss, premature delivery, and intrauterine growth restriction. 2 -4 Gross examination of an affected placenta reveals a thickened maternal floor associated with a yellow network of fibrinoid material that surrounds the villous tissues. 5 Naeye noted that MFI placentas have an increased number of small villi and excessive syncytial trophoblastic knots for gestational age, both of which are associated with a low flow state. 6 Several authors have postulated that the pathologic process described with MFI causes placental insufficiency leading to adverse pregnancy outcome. 2 -4 We postulated that the abnormal uteroplacental perfusion also affects the developing brain, therefore placing affected infants at risk for ischemic injury, particularly to the cerebral white matter, resulting in abnormal neonatal cranial ultrasound findings and adverse neurodevelopmental outcome. The purpose of this study is to compare the cranial ultrasound findings and neurodevelopmental outcome of affected infants born in our institution from 1990 to 1998 to a cohort of gestational age-matched controls.
MATERIALS AND METHODS Study Population
A reproductive pathologist routinely examined the placenta of all deliveries at the University of California San Diego (UCSD), San Diego until June 1995. Subsequently, the placentas of all preterm and high-risk deliveries have been examined. A placental pathologist (K.B., R.N.B.) made the diagnosis of MFI based on accepted criteria for the diagnosis, including gross and microscopic evidence of excessive fibrinoid material in the villous tissues.
All preterm infants ( <37 weeks' gestation) born to mothers diagnosed with maternal floor infarction (MFI) at UCSD from January 1, 1990 to December 31, 1998 are the subjects of this report.
MFI cases were matched for gestational age, sex, and date of birth with two control infants enrolled in the neurodevelopmental followup program upon discharge from the UCSD neonatal intensive care unit. Exclusion criteria included major congenital anomalies or evidence of congenital infection. Term infants were excluded from the case/control study due to the inability to identify an appropriate
OBJECTIVE:
To compare cranial ultrasound studies and neurodevelopmental outcome of preterm infants affected by maternal floor infarction ( MFI ) of the placenta to gestational age -matched controls over an 8 -year period from a single institution.
STUDY DESIGN:
Retrospective case / control study.
RESULTS:
Compared to gestational age -matched controls, infants born to mothers with MFI had a higher incidence of CNS injury on neonatal cranial ultrasound examinations and at follow -up were more likely to have a suspicious or abnormal neurologic examination. MFI cases had lower developmental scores in all areas tested and were more likely to have neurodevelopmental impairment. 
CONCLUSION:

Definitions
Gestational age was based on the best obstetrical estimate using the maternal LMP and/or early fetal ultrasound. The Dubowitz examination 7 was used if this information was unknown. Intrauterine growth restriction was defined as birth weight >2 SD below the mean for gestational age ( <3rd percentile) based on the Usher and McClean criteria. 8 Head circumference >2 SD below the mean for gestational age ( <3rd percentile) was considered abnormal.
Central nervous system abnormalities were identified by serial cranial ultrasounds performed using a sector scanner (Advanced Technologies Laboratories, Bellevue, WA) with a 5-and 7.5-MHz transducer using the technique previously described. 9 All patients 13 which evaluates adaptive, language, personal/social, fine motor, and gross motor skills. Scores for individual skill areas were combined to derive composite mental (adaptive, language, and personal/social) and composite motor (gross motor and fine motor) scores. Two patients were evaluated using the Bayley Scales of Infant Development.
14 One infant with cerebral palsy and severe developmental delays was assessed using the Vineland Adaptive Behavior Scale. 15 Developmental performance was age adjusted and scores were standardized to a population mean of 100.
Neuromotor outcome was categorized as normal, suspicious (hypotonia, hypertonia, or asymmetry) or abnormal (cerebral palsy). The degree of overall impairment was categorized as normal (mental and motor score !85 and normal neurologic examination), mild (borderline composite mental or motor score 75 to 85 and suspicious neurologic exam), moderate (borderline composite mental or motor score 75 to 85 and abnormal neurologic examination), or severe (abnormal composite mental or motor score <75 and abnormal neurologic examination). 16 
Statistical Analysis
Categorical variables are compared using Fischer's exact or likelihood ratio -squared analysis. Continuous variables are assessed using Student's t-tests. Results are expressed as the mean±standard deviation unless otherwise noted. Multivariate linear and logistic regressions were performed to determine which maternal, perinatal, and neonatal factors were independent predictors of neurodevelopmental outcome. R 2 values express the population variance in the multiple linear regression models. Significance is defined as p 0.05; 95% confidence intervals are included. Each infant and the two matched controls are represented once by the most recent follow-up examination.
RESULTS
Population
The overall frequency of MFI was 0.06% (44 cases/7239 placentas) or 6 cases per 1000 placentas examined. The incidence was the same for the period when all placentas were evaluated and the period when only high-risk deliveries were screened. The 44 MFI cases identified during the study period were born to 40 mothers. One mother had three affected infants and another had two affected infants, one of whom was a preterm stillbirth with evidence of IUGR. Twenty-four percent of the mothers with pregnancies affected by MFI had a history of a prior stillbirth, compared to none in the control group (p=0.002). Five placentas were sent from outside hospitals for pathology consultation. No additional information was available on the outcome of these infants.
Of the remaining 38 live births, twenty-four (63%) infants were preterm. Of those, twenty-one (87%) had neonatal cranial ultrasound studies including all MFI cases born at <34 weeks' gestation. There were three deaths among the cases. One neonatal death was due to extreme prematurity and severe respiratory distress syndrome, one infant died at age 11 months due to sequelae of Serratia meningitis, and one infant with trisomy 21 died at 8 months of age after surgical repair of congenital heart disease.
Follow-up sample. Ten (48%) of the 21 surviving preterm MFI cases had both cranial ultrasound examinations and neurodevelopmental follow-up at !10 months adjusted age. 71% of MFI cases <34 weeks gestation are included in the follow-up cohort.
Maternal and Neonatal Demographics
There were no significant differences in the maternal and antenatal variables, except that mothers of control infants had a higher mean age and were more likely to have chorioamnionitis (Table 1A and B). Two MFI cases and one control infant were potentially TRH exposed due to enrollment in the North American TRH Study Group trial. 17 The placenta pathology diagnoses of the controls were: 33 immature, 11 infarction, 6 congestion, 6 deciduitis, 5 Tenney Parker changes, 5 chorioamnionitis/ inflammation, 5 atherosis, 4 retroplacental hematoma, and 1 single umbilical artery.
The mean gestational age for cases and matched controls was 30±3.5 weeks. The mean birth weight for MFI cases was lower than controls, but not statistically different. IUGR was significantly more common among MFI cases than controls. Fifty-seven percent of cases and matched controls were males. There were no significant differences in the racial distribution between cases and controls. There were no significant differences in the neonatal morbidity between cases and controls. Controls were more likely to survive.
Neonatal Cranial Ultrasound Findings
The subjects for this analysis were the 21 infants and their gestational age-matched controls with neonatal cranial ultrasound examinations (see Table 2 ). Ultrasound evidence of Grade III to IV IVH, ED, PVL, and VD were more common in MFI cases compared to controls. Evidence of WMI was significantly different between the two groups when the comprehensive definition of WMI, including PVL and/or persistent EDs with ventricular dilatation (WMI) was used (38% vs 14%, p=0.036). Using multivariate logistic regression, the overall risk of WMI was reduced by each week of increasing gestational age (OR=0.76, 95% CI 0.60 to 0.95, p=0.02) and increased by the presence of MFI (OR 5.1, 95% CI 1.2 to 20.1, p=0.02). 
Neurodevelopmental Outcome
Follow-up sample. The mean gestational age for the follow-up group was 29±3.6 weeks. The mean adjusted age at follow-up was 29±12 months for cases and 22±6 months for controls (p=ns). The mean birth weight for MFI cases and controls was 947±537 g and 1204±564 g, respectively (p=ns). The subgroup of MFI cases who returned were smaller (1471±556 vs 947±537, p=0.31) and of lower gestational age (32±3.4 vs 29±3.6, p=0.033) compared to those lost to follow-up.
Neurologic outcome. MFI cases were more likely to have a suspicious or abnormal neurologic exam compared to control infants (40% vs 10%, p=0.059), however, only the presence of IVH was associated with a significantly higher risk of a suspicious or abnormal neurologic examination (60% vs 0%, p<0.001). Two MFI cases and one control infant had cerebral palsy.
Developmental outcome. MFI cases had significantly lower developmental scores in all individual and composite assessment areas (Table 3) . By univariate analysis the presence of IVH, VD, ED were all associated with abnormal or suspicious developmental performance. By multivariate linear regression analysis, factors that independently predicted lower scores in individual skill areas and composite mental and motor scores were MFI, IVH, IUGR, and male gender (Table 4) .
Overall impairment. Seventy percent of MFI cases had some degree of neurologic and/or developmental impairment (40% mild, 0% moderate, 30% severe) compared to 20% of controls (10% mild, 5% moderate, 5% severe, p=0.024). The presence of MFI (OR 14, 95% CI 2 to 163, p=0.037) and IVH (OR 31, 95% CI 3 to 367, p=0.007) were the only variables that independently predicted overall neurodevelopmental impairment.
DISCUSSION
There are numerous reports of the adverse pregnancy outcomes associated with MFI; however, only limited information is available concerning the neurodevelopmental outcome of surviving infants. Our institutional practice of routine placental examination for all high-risk deliveries provides a unique opportunity to evaluate the outcome of preterm infants born to mothers with MFI. We speculate that the pathologic features associated with MFI create an environment of abnormal uteroplacental perfusion resulting in poor pregnancy outcome and CNS injury. Several authors have followed large prospective cohorts of preterm infants and found that PVL is both specific for and predictive of adverse neurodevelopmental outcome and disabling cerebral palsy. 11,18 -20 Others have shown that persistent EDs and VD are also predictive of adverse neurodevelopmental outcome, most likely because they represent more subtle and/or diffuse injury to the underlying periventricular white matter. These findings support a broader definition of WMI than cystic PVL alone.
In our series, infants born to mothers with MFI of the placenta were more likely to have abnormalities on neonatal cranial ultrasound, including evidence of WMI. The trend toward an increased incidence of isolated PVL may have been significant if the sample was larger.
Compared to matched controls, MFI cases had lower performance scores in all developmental areas assessed, were more likely to have suspicious or abnormal neurologic exams, and were more likely to be neurodevelomentally impaired. The only other data describing the developmental outcome of infants affected by MFI are from the 1959 to 1966 Collaborative Perinatal Trial. 6 Thirty-eight infants were assessed using the Bayley Scale of Infant Development at 8 months of age; no difference was found between cases and controls. However, only 26% of Naeyes' subjects were preterm and the follow-up duration was very limited. In our series, we evaluated only preterm infants who represent the highest risk group for adverse neurodevelopmental outcome. Inclusion of large numbers of less severely affected term infants may minimize the differences between cases and controls. In addition, we included only infants with neurodevelopmental assessments performed beyond 10 months adjusted age because neurodevelopmental outcome often improves during early childhood and abnormalities in neuromotor tone may not be evident at earlier examinations.
The generalizability of the conclusions from our study is limited by the small sample size; however, MFI is a rare disorder. A selection bias was introduced by the exclusion of term infants with MFI and because those premature infants who returned for follow-up tended to be smaller and born at lower gestational ages. However, these very low birth weight infants are the most severely affected fetuses and therefore represent the highest risk group for adverse neurodevelopmental outcome. Strengths of our study include the complete ascertainment of MFI cases during the study period due to routine placental examination of all high-risk deliveries and the unique awareness of this disorder in our pathology department. We also matched MFI cases and controls for known confounders of neurodevelopmental outcome and accounted for secular changes in obstetrical and neonatology practice by matching for date of birth.
The difference in neurodevelopmental outcome between the two groups was striking. The presence of MFI of the placenta was independently predictive for adverse neurodevelopmental outcome, which suggests that MFI may have more subtle effects on CNS injury than evidenced by neonatal cranial ultrasound examinations alone. Because our follow-up period extended only through early childhood, and included primarily very immature infants, further research is needed to determine long-term neurodevelopmental risk associated with MFI for both preterm and term infants.
Our study shows that MFI of the placenta has important implications for the developing fetus that extend beyond the perinatal period. Increasing awareness of MFI as an entity that presents Adams -Chapman et al.
Maternal Floor Infarction of the Placenta significant physical risks to the fetus and developmental risks to the infant will enable physicians to provide appropriate maternal counseling for subsequent pregnancies and adequate follow-up for the surviving infants. We recommend that all infants born to mothers with MFI have serial cranial ultrasound examinations after birth, including a study at least 1 month after birth to detect evolving evidence of CNS injury, in particular WMI. Neurodevelopmental follow-up throughout early childhood is imperative to identify problems as soon as possible and assure appropriate intervention.
